Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ

Can I sell a private label tranexamic acid SPF 30 cream in the EU and UK?

By Blake Mereby · Last reviewed October 3, 2026

Yes, but the regulatory framework is entirely different from the United States, and a formula compliant for US sale may require meaningful reformulation before it can legally enter EU or UK markets.

In the European Union, SPF products are regulated as cosmetics under Regulation (EC) No 1223/2009, not as drugs. This is the opposite of the US approach. There is no "OTC drug" category for sunscreens in Europe; SPF is treated as a cosmetic claim, and UV filters are governed by Annex VI of the EU Cosmetics Regulation. The approved UV filter list under Annex VI differs significantly from the FDA's OTC Monograph list. For example, bemotrizinol (Tinosorb S) and bisoctrizole (Tinosorb M) are permitted in Europe but are not on the FDA monograph — and conversely, some US-common filters like oxybenzone face restrictions in certain EU member states. If your US formula uses filter combinations not on Annex VI, you must reformulate for European distribution.

For EU market access, your product must also undergo a Cosmetic Product Safety Assessment (CPSA) performed by a qualified Person Responsible (PR) — a toxicologist or similarly credentialed professional — and the product must be notified in the CPNP (Cosmetic Products Notification Portal) before it goes on sale in any EU member state. The safety assessment typically costs €800–€3,000 per product and takes 4–8 weeks depending on the assessor's queue.

Post-Brexit, the United Kingdom operates its own cosmetics regulation (UK Cosmetics Regulation, retained from EU law) and requires a UK Responsible Person and notification on the SCPN (UK's equivalent of CPNP). If you're selling in both EU and UK, you need a separate RP and notification in each jurisdiction.

Transexamic acid itself is not a restricted ingredient in either EU or UK cosmetics regulations as of 2024, and there are no concentration limits specifically for TXA in the EU Cosmetics Regulation Annexes at the concentrations typically used in face creams (2–5%). However, your safety assessor will review TXA at the intended concentration as part of the CPSA and will flag any concerns.

Founders targeting both US and EU markets often develop two formula variants from the same manufacturer — one with an FDA-monograph-compliant filter system and one with an EU Annex VI-compliant filter system — sharing the same TXA brightening base. This approach minimizes development cost while achieving dual-market compliance. AJ Cosmo Labs can connect you with cosmetic chemists and contract manufacturers experienced in multi-market SPF compliance, which is a specialized subset of the broader cosmetic manufacturing community.

Read the full guide on Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ →

More about Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app